Literature DB >> 15226483

Mild impairment of motor nerve repair in mice lacking PTP-BL tyrosine phosphatase activity.

Derick G Wansink1, Wilma Peters, Iris Schaafsma, Roger P M Sutmuller, Frank Oerlemans, Gosse J Adema, Bé Wieringa, Catharina E E M van der Zee, Wiljan Hendriks.   

Abstract

Mouse PTP-BL is a large, nontransmembrane protein tyrosine phosphatase of unclear physiological function that consists of a KIND domain, a FERM domain, five PDZ domains, and a COOH-terminal catalytic PTP domain. PTP-BL and its human ortholog PTP-BAS have been proposed to play a role in the regulation of microfilament dynamics, cytokinesis, apoptosis, and neurite outgrowth. To investigate the biological function of PTP-BL enzyme activity, we have generated mice that lack the PTP-BL PTP moiety. These PTP-BL(DeltaP/DeltaP) mice are viable and fertile and do not present overt morphological alterations. Although PTP-BL is expressed in most hematopoietic cell lineages, no alterations of thymocyte development in PTP-BL(DeltaP/DeltaP) mice could be detected. Sciatic nerve lesioning revealed that sensory nerve recovery is unaltered in these mice. In contrast, a very mild but significant impairment of motor nerve repair was observed. Our findings exclude an essential role for PTP-BL as a phosphotyrosine phosphatase and rather are in line with a role as scaffolding or anchoring molecule.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15226483     DOI: 10.1152/physiolgenomics.00079.2004

Source DB:  PubMed          Journal:  Physiol Genomics        ISSN: 1094-8341            Impact factor:   3.107


  18 in total

Review 1.  Prophase I arrest and progression to metaphase I in mouse oocytes: comparison of resumption of meiosis and recovery from G2-arrest in somatic cells.

Authors:  Petr Solc; Richard M Schultz; Jan Motlik
Journal:  Mol Hum Reprod       Date:  2010-05-07       Impact factor: 4.025

2.  PTPL1/PTPN13 regulates breast cancer cell aggressiveness through direct inactivation of Src kinase.

Authors:  Murielle Glondu-Lassis; Mathilde Dromard; Magali Lacroix-Triki; Philippe Nirdé; Carole Puech; Dora Knani; Dany Chalbos; Gilles Freiss
Journal:  Cancer Res       Date:  2010-05-25       Impact factor: 12.701

3.  The receptor protein tyrosine phosphatase LAR promotes R7 photoreceptor axon targeting by a phosphatase-independent signaling mechanism.

Authors:  Kerstin Hofmeyer; Jessica E Treisman
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-04       Impact factor: 11.205

Review 4.  PTPN13/PTPL1: an important regulator of tumor aggressiveness.

Authors:  Gilles Freiss; Dany Chalbos
Journal:  Anticancer Agents Med Chem       Date:  2011-01       Impact factor: 2.505

5.  Valosin containing protein (VCP/p97) is a novel substrate for the protein tyrosine phosphatase PTPL1.

Authors:  Ogan D Abaan; Wiljan Hendriks; Aykut Uren; Jeffrey A Toretsky; Hayriye V Erkizan
Journal:  Exp Cell Res       Date:  2012-09-24       Impact factor: 3.905

6.  The PDZ binding motif of human papillomavirus type 16 E6 induces PTPN13 loss, which allows anchorage-independent growth and synergizes with ras for invasive growth.

Authors:  William C Spanos; Andrew Hoover; George F Harris; Shu Wu; Guinevere L Strand; Mary E Anderson; Aloysius J Klingelhutz; Wiljan Hendriks; Aaron D Bossler; John H Lee
Journal:  J Virol       Date:  2007-12-26       Impact factor: 5.103

Review 7.  Protein tyrosine phosphatases as potential therapeutic targets.

Authors:  Rong-Jun He; Zhi-Hong Yu; Ruo-Yu Zhang; Zhong-Yin Zhang
Journal:  Acta Pharmacol Sin       Date:  2014-09-15       Impact factor: 6.150

Review 8.  PTPL1: a large phosphatase with a split personality.

Authors:  Ogan D Abaan; Jeffrey A Toretsky
Journal:  Cancer Metastasis Rev       Date:  2008-06       Impact factor: 9.264

9.  Expression of the putative tumor suppressor gene PTPN13/PTPL1 is an independent prognostic marker for overall survival in breast cancer.

Authors:  Françoise Révillion; Carole Puech; Fanja Rabenoelina; Dany Chalbos; Jean-Philippe Peyrat; Gilles Freiss
Journal:  Int J Cancer       Date:  2009-02-01       Impact factor: 7.396

10.  Impaired PTPN13 phosphatase activity in spontaneous or HPV-induced squamous cell carcinomas potentiates oncogene signaling through the MAP kinase pathway.

Authors:  A C Hoover; G L Strand; P N Nowicki; M E Anderson; P D Vermeer; A J Klingelhutz; A D Bossler; J V Pottala; W J A J Hendriks; J H Lee
Journal:  Oncogene       Date:  2009-09-07       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.